WO1993012657A1 - Wundantiseptikum - Google Patents
Wundantiseptikum Download PDFInfo
- Publication number
- WO1993012657A1 WO1993012657A1 PCT/EP1992/002876 EP9202876W WO9312657A1 WO 1993012657 A1 WO1993012657 A1 WO 1993012657A1 EP 9202876 W EP9202876 W EP 9202876W WO 9312657 A1 WO9312657 A1 WO 9312657A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogen peroxide
- iodine
- wound
- aqueous physiological
- physiological solutions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Definitions
- the intact skin which has a natural protective function and largely protects the human body against infections by microorganisms, generally does not need to be disinfected.
- An exception applies to doctors, nursing staff, etc.
- it should always be disinfected after thorough cleaning in order to prevent infectious agents from penetrating into the wound area and the surrounding tissue or even into the blood to prevent web.
- a wound is any violent severing or destruction of the skin, mucous membrane, deeper tissues or internal organs caused by external influences such as violence, heat, cold, chemicals or radiation. Depending on the cause of their occurrence, a large number of wounds can be distinguished, which are quite different in terms of their external characteristics and can accordingly show different risks of infection.
- PVP-iodine preparations which contain polyvinylpyrrolidone-iodine complexes with 10% available iodine, are market leaders in disinfectant wound treatment.
- Iodine has been used for about 150 years in the form of a mostly ethanolic tincture of iodine or an aqueous solution (both with the addition of KJ) for wound disinfection.
- Many studies have been carried out on the compatibility of iodine solutions. They show that although iodine is one of the most effective antiseptics in the field, it also has some disadvantages. This is how iodine is absorbed through the skin. This leads to an increase in the serum iodine level and can result in systemic side effects. Allergic reactions occur in approx. 1% of the applications. With unexplained thyroid function, iodine-induced hyperthyroidism can occur.
- Iodophores are complexes of high molecular, surface-active carriers with iodine.
- the most common is the polyvinylpyrrolidone-iodine complex (PVP-iodine) mentioned at the beginning with 10% available iodine.
- PVP-iodine polyvinylpyrrolidone-iodine complex
- the spectrum of activity corresponds essentially to that of elemental iodine.
- the human tolerance of PVP-iodine is also controversial and is controversially discussed in the literature. Since iodine is also absorbed through the skin here, the side effects of the PVP-iodine complexes correspond to the side effects of pure iodine.
- compositions containing hydrogen peroxide for dermatological or disinfecting purposes is e.g. from German Offenlegungsschrift 32 05 318, German Patent 23 27 181, British Patent 1 539 771 and Chemiker-Zeitung, 99. (1975), pages 132-137.
- Hydrogen peroxide is a colorless, water-clear, almost odorless, weakly acidic liquid that can be mixed with water in any ratio. Likewise, it is readily soluble in a large number of organic solvents and pharmaceutical auxiliaries. Hydrogen peroxide has a broad spectrum of activity against bacteria, fungi and viruses. Depending on the concentration and exposure time, it has a microbistatic or icrobicidal effect.
- aqueous hydrogen peroxide solutions The stability of aqueous hydrogen peroxide solutions is very dependent on the pH. At low concentrations, inactivating components can often not be adequately compensated for, while interference factors are largely eliminated from ⁇ 3% H2O2 content.
- Complexing agents such as 8-hydroxy-quinoline, but also lower, aliphatic alcohols (ethanol, n-propanol, iso-propanol) are predominantly used to stabilize aqueous hydrogen peroxide solutions against catalytically active metal ions.
- Bis-guanidine derivatives such as chlorhexidine have also been used as anti-microbial agents for years.
- the concentration of hydrogen peroxide in the agent can be about 0.05 to 3, preferably about 1.5 to 3, in particular about 2 to 3% by weight.
- the concentration of phenoxyethanol can also be about 0.05 to 3, preferably about 1.5 to 3, in particular about 2 to 3% by weight.
- An addition of about 0.01 to 0.1% by weight, preferably of about 0.025 to 0.04% by weight, of 8-hydroxyquinoline also acts as a stabilizer for hydrogen peroxide, but develops in this concentration no special own anti-microbial activity.
- test germs here: Staphylococcus aureus, Pseudomonas aeruginosa
- the closed petri dishes were incubated at 37 ° C. for the duration of the exposure.
- the gauze compresses were removed after an exposure time of 2 hours, 4 hours and 24 hours.
- An agar stamping was removed from the zone of the germ agar previously covered with gauze using a cork borer. This was taken up in an inactivation solution, homogenized and the bacterial count was determined.
- a water value gauge compress soaked in water
- Standardized undiluted PVP-iodine solution (commercial preparation Betaisodona, Mundipharma, 10% available iodine) was tested as a reference substance.
- the reduction factor for the reference substance was 0.42 after 2 hours and 3.68 after 24 hours.
- the recipe was easy to assemble in this form (see below). It was also tested with the Staphylococcus aureus and Pseudomonas aeruginosa bacteria under blood stress. The results (reduction factors) of these tests were very good.
- the reference substance (Betaisodona, Mundiphar a) showed the following antimicrobial effects:
- Staphylococcus aureus > 5.29 4.8> 5.29 Pseudomonas aeruginosa> 5.7> 5.7> 5.7
- the hydrogen peroxide content of some selected solutions was regularly determined.
- the hydrogen peroxide content was determined using a 686 titroprocessor from Methro (TFC-OC, H. Vogelr) by iodometric titration.
- a defined amount of the solution to be tested is mixed with 20 ml of isopropanol and distilled water, acidified with 10 ml of 10% sulfuric acid and 1 ml of 3% molybdate solution. After adding a spatula tip of potassium iodide, titrate immediately with a 0.1 N sodium thiosulfate solution.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5511388A JPH07502518A (ja) | 1991-12-20 | 1992-12-11 | 傷の消毒剤 |
DE59207556T DE59207556D1 (de) | 1991-12-20 | 1992-12-11 | Wundantiseptikum |
EP92924720A EP0618768B1 (de) | 1991-12-20 | 1992-12-11 | Wundantiseptikum |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4142319.4 | 1991-12-20 | ||
DE4142319A DE4142319A1 (de) | 1991-12-20 | 1991-12-20 | Wundantiseptikum |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993012657A1 true WO1993012657A1 (de) | 1993-07-08 |
Family
ID=6447721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1992/002876 WO1993012657A1 (de) | 1991-12-20 | 1992-12-11 | Wundantiseptikum |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0618768B1 (de) |
JP (1) | JPH07502518A (de) |
DE (2) | DE4142319A1 (de) |
WO (1) | WO1993012657A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0899873A (ja) * | 1994-09-30 | 1996-04-16 | Kobayashi Pharmaceut Co Ltd | エアゾール型発泡性傷口洗浄消毒剤 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9028858B2 (en) | 2003-02-26 | 2015-05-12 | Coloplast A/S | Assembly for the preparation of a medical device having a coating comprising hydrogen peroxide |
US8501223B2 (en) | 2003-06-20 | 2013-08-06 | Hill's Pet Nutrition, Inc. | Methods for dietary management of cats to avoid hyperthyroidism |
JP4586018B2 (ja) * | 2003-06-20 | 2010-11-24 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 猫における甲状腺機能亢進症を予防する方法及び限定されたヨウ素を含む組成物 |
JP2011524217A (ja) | 2008-06-16 | 2011-09-01 | コロプラスト アクティーゼルスカブ | 滅菌された親水性コーティングを照射するための緩衝された膨潤性媒体 |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2451149A (en) * | 1942-11-16 | 1948-10-12 | Nipa Lab Ltd | Manufacture of materials resistant to or active against microorganisms |
FR1539262A (fr) * | 1966-09-21 | 1968-09-13 | Vick Internat Ltd | Produit pour le nettoyage de la peau |
FR1583994A (de) * | 1967-07-15 | 1969-12-12 | ||
FR2356600A1 (fr) * | 1976-06-29 | 1978-01-27 | Peroxid Chemie Gmbh | Agent germicide pour systemes aqueux a base de peroxyde d'hydrogene et son utilisation |
DE2811756A1 (de) * | 1977-03-18 | 1978-09-21 | Chemisches Inst Schaefer Ag Ob | Reinigerkonzentrat mit einem gehalt an ionischen und nichtionischen tensiden |
GB1539771A (en) * | 1976-09-01 | 1979-02-07 | Quinoderm Ltd | Dermatological compositions |
EP0016319A1 (de) * | 1979-02-05 | 1980-10-01 | Henkel Kommanditgesellschaft auf Aktien | Desinfektionsmittel auf Basis von Alkoholen und seine Verwendung zur Hautdesinfektion |
EP0231080A1 (de) * | 1986-01-16 | 1987-08-05 | Imperial Chemical Industries Plc | Antiseptische Zusammensetzungen |
EP0252278A2 (de) * | 1986-06-09 | 1988-01-13 | Henkel Kommanditgesellschaft auf Aktien | Desinfektionsmittel und ihre Verwendung zur Haut- und Schleimhautdesinfektion |
EP0383005A1 (de) * | 1989-02-11 | 1990-08-22 | SchàLke & Mayr Gmbh | Konservierungsmittel für Systeme oder Produkte mit einer wässrigen Phase |
EP0411315A1 (de) * | 1989-08-02 | 1991-02-06 | SchàLke & Mayr Gmbh | Wässrige antiseptische Zusammensetzung |
WO1991002538A1 (en) * | 1989-08-18 | 1991-03-07 | John Morris Co., Inc. | Odor-masked and stabilized compositions for treating keratinous tissue, skin conditions, and promoting wound healing |
US5043484A (en) * | 1990-02-09 | 1991-08-27 | Texaco Chemical Company | Synthesis of hydroxyl-terminated polybutadienes using glycol ether solvents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH587866A5 (de) * | 1972-07-29 | 1977-05-13 | Roehm Gmbh | |
US3841971A (en) * | 1973-02-16 | 1974-10-15 | Corning Glass Works | Synergistic enzymes adsorbed within porous inorganic carriers |
US3982997A (en) * | 1974-09-18 | 1976-09-28 | Corning Glass Works | Immobilized glucose isomerase |
GB1525022A (en) * | 1975-05-21 | 1978-09-20 | Beecham Group Ltd | Cell culture method |
-
1991
- 1991-12-20 DE DE4142319A patent/DE4142319A1/de not_active Withdrawn
-
1992
- 1992-12-11 DE DE59207556T patent/DE59207556D1/de not_active Expired - Fee Related
- 1992-12-11 JP JP5511388A patent/JPH07502518A/ja active Pending
- 1992-12-11 WO PCT/EP1992/002876 patent/WO1993012657A1/de not_active Application Discontinuation
- 1992-12-11 EP EP92924720A patent/EP0618768B1/de not_active Revoked
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2451149A (en) * | 1942-11-16 | 1948-10-12 | Nipa Lab Ltd | Manufacture of materials resistant to or active against microorganisms |
FR1539262A (fr) * | 1966-09-21 | 1968-09-13 | Vick Internat Ltd | Produit pour le nettoyage de la peau |
FR1583994A (de) * | 1967-07-15 | 1969-12-12 | ||
FR2356600A1 (fr) * | 1976-06-29 | 1978-01-27 | Peroxid Chemie Gmbh | Agent germicide pour systemes aqueux a base de peroxyde d'hydrogene et son utilisation |
GB1539771A (en) * | 1976-09-01 | 1979-02-07 | Quinoderm Ltd | Dermatological compositions |
DE2811756A1 (de) * | 1977-03-18 | 1978-09-21 | Chemisches Inst Schaefer Ag Ob | Reinigerkonzentrat mit einem gehalt an ionischen und nichtionischen tensiden |
EP0016319A1 (de) * | 1979-02-05 | 1980-10-01 | Henkel Kommanditgesellschaft auf Aktien | Desinfektionsmittel auf Basis von Alkoholen und seine Verwendung zur Hautdesinfektion |
EP0231080A1 (de) * | 1986-01-16 | 1987-08-05 | Imperial Chemical Industries Plc | Antiseptische Zusammensetzungen |
EP0252278A2 (de) * | 1986-06-09 | 1988-01-13 | Henkel Kommanditgesellschaft auf Aktien | Desinfektionsmittel und ihre Verwendung zur Haut- und Schleimhautdesinfektion |
EP0383005A1 (de) * | 1989-02-11 | 1990-08-22 | SchàLke & Mayr Gmbh | Konservierungsmittel für Systeme oder Produkte mit einer wässrigen Phase |
EP0411315A1 (de) * | 1989-08-02 | 1991-02-06 | SchàLke & Mayr Gmbh | Wässrige antiseptische Zusammensetzung |
WO1991002538A1 (en) * | 1989-08-18 | 1991-03-07 | John Morris Co., Inc. | Odor-masked and stabilized compositions for treating keratinous tissue, skin conditions, and promoting wound healing |
US5043484A (en) * | 1990-02-09 | 1991-08-27 | Texaco Chemical Company | Synthesis of hydroxyl-terminated polybutadienes using glycol ether solvents |
Non-Patent Citations (1)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 13, no. 224 (C-599)(3572) 24. Mai 1989 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0899873A (ja) * | 1994-09-30 | 1996-04-16 | Kobayashi Pharmaceut Co Ltd | エアゾール型発泡性傷口洗浄消毒剤 |
Also Published As
Publication number | Publication date |
---|---|
DE59207556D1 (de) | 1997-01-02 |
EP0618768A1 (de) | 1994-10-12 |
EP0618768B1 (de) | 1996-11-20 |
JPH07502518A (ja) | 1995-03-16 |
DE4142319A1 (de) | 1993-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60025369T2 (de) | Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden | |
EP0700249B1 (de) | Antiinfektivum | |
EP1685854B2 (de) | Viruzides Desinfektionsmittel | |
CN101646342A (zh) | 消毒剂 | |
DE10224979B4 (de) | Verwendung von synergistischen Zubereitungen auf Basis von Gemischen von Glycerinether mit aromatischem Alkohol zur Bekämpfung von Mykobakterien | |
CN106818837B (zh) | 生物抗菌多肽制剂、制备方法及其应用 | |
DE10106444C2 (de) | Mittel zur viruziden Händedesinfektion | |
EP0016319B1 (de) | Desinfektionsmittel auf Basis von Alkoholen und seine Verwendung zur Hautdesinfektion | |
EP2489370A1 (de) | Verwendung einer synergistischen Zusammensetzung als therapeutisches Mittel oder Desinfektionsmittel | |
Stawarz-Janeczek et al. | Disinfectants used in stomatology and SARS-CoV-2 infection | |
EP0264658A1 (de) | Flüssige sterilisierende Zusammensetzung | |
EP0618768B1 (de) | Wundantiseptikum | |
DE3046769C3 (de) | Die Verwendung von Caroat als viruzides Mittel | |
EP1135116A1 (de) | Verwendung von poly (hexamethylen) biguanid zur herstellung eines mittels zur förderung der heilung von infektionsfreien wunden | |
DE3832161A1 (de) | Mikrobizide zubereitungen und deren anwendungen | |
DK166761B1 (da) | Praeparat indeholdende jod og anvendelse af dette til desinfektion | |
DE10237227B4 (de) | Verwendung von Vitamin C und/oder seinen Derivaten als antivirale Wirkstoffe in alkoholischen Desinfektionsmitteln | |
EP1020115B1 (de) | Desinfektionsmittel und Antiseptikum auf der Basis von Alkoholen | |
DE19901526B4 (de) | Desinfektionsmittel und Antiseptikum auf der Basis von Alkoholen | |
DE4200499A1 (de) | Desinfektionsmittel | |
KR102267156B1 (ko) | 살균 및 소독용 조성물 및 그 제조방법 | |
US11744249B2 (en) | Disinfectants with iodine and copper complexes for use against coronavirus | |
DE2427702C2 (de) | Antiseptische Jodophorlösung | |
EP0940080B1 (de) | Desinfektionsmittel und Antiseptikum auf der Basis von Alkoholen | |
EP2008516A1 (de) | Verwendung eines alkoholischen Desinfektionsmittels zur Schnelldesinfektion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1992924720 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1994 244989 Date of ref document: 19940711 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1992924720 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1992924720 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992924720 Country of ref document: EP |